Insider trade

Director received an award of 55.56 TMO derivative securities

Traded Sep 26, 2026 · Filed Sep 29, 2026

Thermo Fisher ScientificTMO

55.56
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 26, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 29, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001580693-26-000002
Filed / recorded

Sep 29, 2026, 8:14 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

THERMO FISHER SCIENTIFIC INC.

Issuer CIK

97745

Ticker

TMO

Reporting person

Dion J Weisler

Relationship

Director

Security

Phantom Stock Units

Table

Derivative (Table II)

Transaction date

Sep 26, 2026

Transaction code

A

Shares / units

55.56

Acquired / disposed

Acquired (A)

Shares owned after

2,846.55

Ownership form

Direct

Amendment

No

Footnotes from the filing

Convertible into Common Stock on a 1-for-1 basis.
Represents stock units credited to the Reporting Person's account as of September 26, 2026, at a price of $675.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.